IUBMB Life · 2018 · 21 citations · 34 references
Life SciencesBiomedical SciencesCell BiologyGene ExpressionRegenerative MedicineStem Cell BiologyOxidative StressStem Cell DifferentiationDifferentiation CapacityHeme Oxygenase SignalingInduced Pluripotent Stem Cell DifferentiationInduced Pluripotent Stem Cell ModelsMicrorna In Stem Cell RegulationPluripotencyReprogrammingReprogramming Efficiency
Abstract Cellular stress can influence efficiency of iPSCs generation and their differentiation. However, the role of intracellular cytoprotective factors in these processes is still not well known. Therefore, we investigated the effect of HO‐1 ( Hmox1 ) or Nrf2 ( Nfe2l2 ), two major cytoprotective genes. Hmox1 –/– fibroblasts demonstrated decreased reprogramming efficiency in comparison to Hmox1 +/+ cells. Reversely, pharmacological enhancement of HO‐1 resulted in higher number of iPSCs colonies. Importantly, elevated level of both p53 and p53‐regulated miR‐34a and 14‐3‐3σ was observed in HO‐1‐deficient fibroblasts whereas downregulation of p53 in these cells markedly increased their reprogramming efficiency. In human fibroblasts HO‐1 silencing also induced p53 expression and affected reprogramming outcome. Hmox1 +/+ and Hmox1 –/– iPSCs similarly differentiated in vitro to cells originating from three germ layers, however, lower number of contracting cells was observed during this process in HO‐1‐deficient cells indicating attenuated cardiac differentiation. Importantly, silencing of Hmox1 in murine ESC using CRISPR/Cas‐9 editing also impaired their spontaneous cardiac differentiation. Decreased reprogramming efficiency was also observed in Nrf2‐lacking fibroblasts. Reversely, sulforaphane, a Nrf2 activator, increased the number of iPSCs colonies. However, both Nfe2l2 +/+ and Nfe2l2 –/– iPSCs showed similar pluripotency and differentiation capacity. These results indicate that regulation of HO‐1 expression can further optimize generation and cardiac differentiation of iPSCs. © 2018 IUBMB Life, 70(2):129–142, 2018
34
Genome engineering using the CRISPR-Cas9 system
F. Ann Ran, Patrick D. Hsu, Jason Wright et al. · Nature Protocols · 2013 · 11.7K citations · Full text
Suppression of induced pluripotent stem cell generation by the p53–p21 pathway
Hyenjong Hong, Kazutoshi Takahashi, Tomoko Ichisaka et al. · Nature · 2009 · 1.3K citations · Full text
Is a p53-Regulated Inhibitor of G2/M Progression
Heiko Hermeking, Christoph Lengauer, Kornélia Polyák et al. · Molecular Cell · 1997 · 1.2K citations · Full text